Generic SupplierYour reliable supplier of generic medications
$0.00 (0 items)Checkout

Categories list

Social bookmarks:

Our billing is certified by:

Secure shopping certificates

Special Offer!

Generic Cyclophosphamide - Cytoxan

Search by letter:

ABCDEFGHIJKLMNOPQRSTUVWXYZ
 
 
 
Cytoxan $0.83
Per pill
CytoxanCyclophosphamide 50mg
Buy now!
 
quicksearch
quicksearch

Delivery was successful.
Thank you about the gifting extrapack you promised.
It's a pleasure to work with you, and I'll get business with you next times.
Thank you overall. - Best regards


Moneyback Guarantee
bookmark Bookmark this site
Subscribe to the News

Latest News

  • Rare Phase 3 Salvage Trial in Relapsed Testicular Cancer - Medscape

    Rare Phase 3 Salvage Trial in Relapsed Testicular CancerMedscapeThe single high-dose chemotherapy regimen consisted of 3 cycles of etoposide, ifosfamide, and cisplatin (VIP), followed by 1 cycle of high-dose carboplatin, etoposide, and cyclophosphamide.

  • NICE final OK extends use of MabThera - Pharma Times

    NICE final OK extends use of MabTheraPharma TimesEvidence shows that adding MabThera to cyclophosphamide, vincristine and prednisolone (CVP), cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP), mitoxantrone, chlorambucil and prednisolone (MCP) and cyclophosphamide, doxorubicin, .

  • Ziopharm Oncology Says FDA Accepts IND For Oral Palifosfamide - Quick Facts - RTT News

    Ziopharm Oncology Says FDA Accepts IND For Oral Palifosfamide - Quick FactsRTT NewsPalifosfamide is a novel DNA cross-linker in class with bendamustine, ifosfamide, and cyclophosphamide.

  • US FDA accepts Ziopharm's IND for oral palifosfamide - pharmabiz.com

    US FDA accepts Ziopharm's IND for oral palifosfamidepharmabiz.

  • Studies Reignite Debate over Avastin in Breast Cancer - MedPage Today

    MedPage TodayStudies Reignite Debate over Avastin in Breast CancerMedPage TodayAll patients received neoadjuvant epirubicin and cyclophosphamide, followed by docetaxel, and were randomized to bevacizumab or no additional therapy.